Skip Nav Destination
1-7 of 7
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Blood (2017) 130 (Supplement 1): 4159.
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87
U Creutzig, J Harbott, C Sperling, J Ritter, M Zimmermann, H Loffler, H Riehm, G Schellong, WD Ludwig
Blood (1995) 86 (8): 3097–3108.
Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood [letter]
A Cantu-Rajnoldi, A Biondi, M Jankovic, G Masera, A Rovelli, C Uderzo, D Head, S Raimondi, V Creutzig, J Ritter
Blood (1993) 81 (8): 2209–2210.
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group
A Reiter, M Schrappe, WD Ludwig, F Lampert, J Harbott, G Henze, CM Niemeyer, H Gadner, S Muller-Weihrich, J Ritter
Blood (1992) 80 (10): 2471–2478.
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group
Blood (1990) 75 (10): 1932–1940.
Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis
WD Ludwig, CR Bartram, J Ritter, A Raghavachar, W Hiddemann, G Heil, J Harbott, H Seibt-Jung, JV Teichmann, H Riehm
Blood (1988) 71 (6): 1518–1528.
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78
U Creutzig, J Ritter, H Riehm, HJ Langermann, G Henze, H Kabisch, D Niethammer, H Jurgens, B Stollmann, U Lasson
Blood (1985) 65 (2): 298–304.